{"organizations": ["U.S. High School", "PolyMedix Inc.", "Growth Equities, Ltd.", "AAOS", "American Academy of Orthopaedic Surgeons", "Knee Emerging Growth Equities, Ltd", "International Society for Pharmacoeconomics and Outcomes Research", "Kantar Health", "PolyMedix Inc", "Institute on Drug Abuse"], "uuid": "d78e6ebe6182dcd0481e151bb6d885f7041da5d7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Rx-360-Engages-The-C-3DC-Bond-Group-to-Lead-Business-Development-Activities-48059-1/", "country": "US", "title": "Rx-360 Engages The C=C Bond Group to Lead Business Development Activities", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Rx-360 Engages The C=C Bond Group to Lead Business Development Activities", "spam_score": 0.0, "site_type": "news", "published": "2015-09-08T14:32:00.000+03:00", "replies_count": 0, "uuid": "d78e6ebe6182dcd0481e151bb6d885f7041da5d7"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Rx-360-Engages-The-C-3DC-Bond-Group-to-Lead-Business-Development-Activities-48059-1/", "ord_in_thread": 0, "title": "Rx-360 Engages The C=C Bond Group to Lead Business Development Activities", "locations": ["San Diego", "Aurora", "UK", "Colo"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["DeMott", "George DeMott"], "text": " 9/8/2015)... & San Diego, CA (PRWEB) , ... ... ... Optimized Products Group LLC (OPG), a California-based beverage company, announces a cooperative ... Corporation, (OTC: CANV) the leading supplier and producer of award-winning hemp-derived cannabidiol ... (Date:9/8/2015)... Aurora, Colo.   ... ... from infectious disease: Targeting pathogens and parasites with medicines like antibiotics, or dealing ... Nature Scientific Reports demonstrates the effectiveness of a third strategy: Adjusting the landscape ... (Date:9/8/2015)... ... September 08, 2015 , ... Recent episodes of hypoglycemia are ... with type 2 diabetes, according to new findings from Kantar Healthâ€™s National ... the ISPOR (International Society for Pharmacoeconomics and Outcomes Research) 5th Latin America Conference   UK (PRWEB) ,   supporting effective workflow and business analysis in a radiology department; they deliver ease ... high security and privacy as they can be accessed only by authorised users. ... [ 0 ] Pot-O-Coffee and CannaVest Enter Strategic Co-Branding Deal Producing Hemp-Derived CBD Infused Beverages [ 0 ] NATURE: Study Creates Cell Immunity to Parasite That Infects 50 Million [ 0 ] Hypoglycemia Is Associated with Worse Health Outcomes in Type 2 Diabetes [ 0 ] National   World RIS Market to Reach USD 722.7 Mln by 2019, According to MarketsandMarkets Report Available at MarketPublishers.com ... damage to DNA, study says , , THURSDAY, Dec. ... at risk of DNA damage from prolonged exposure to ... 83 airline pilots to 50 university faculty members from ... participants were analyzed for DNA abnormalities, specifically the number ... ... teens is slowing, survey finds , , THURSDAY, Dec. 11 (HealthDay ... teens, the abuse of painkillers such as Vicodin and Oxycontin ... in the use of drugs such as marijuana has stalled ... Institute on Drug Abuse says in its report, Monitoring ... ... The American Academy of Orthopaedic Surgeons (AAOS) has ... of Osteoarthritis of the Knee\". These guidelines were explicitly ... knee replacement surgery. While a wide range of treatment ... patients after discussions with their physicians. , ... ... Growth Equities, Ltd. initiates coverage of PolyMedix Inc. (OTC ... $9.00 price target. PolyMedix focuses on developing novel ... The Company,s leading clinical development programs include the ... , , Emerging Growth ... ... President & CEO , , ... a drug delivery technology company, today announced that George DeMott, chairman ... position as chairman, effective immediately. Mr. DeMott will continue to ... , , The board of directors ... ... serious risk of a long-term hospital stay, and ventilator-associated ... 15% of all people who are ventilated, is among ... a higher resistance to antibiotics, patients who rely on ... as 26,000 Americans do every year. , Thanks to ... Pilots May Face Greater Cancer Risk 10% of U.S. High School Seniors Use Vicodin AAOS Issues New Clinical Practice Guideline for Osteoarthritis of the Knee Emerging Growth Equities, Ltd. Initiates Coverage of PolyMedix Inc. With a Buy Rating and a $9.00 Price Target DelSite Chairman George DeMott Resigns There's a life-saving medical device sitting on your sink  ", "external_links": [], "published": "2015-09-08T14:32:00.000+03:00", "crawled": "2015-09-08T15:39:22.131+03:00", "highlightTitle": ""}